Background. Over the past 15 years, many large university hospitals have reported their experience with percutaneous dilatational tracheostomy (PDT). The purposes of this study are to evaluate the safety of PDT in a non-university hospital setting and to compare our results with those published in the literature.
TRACHEOSTOMY has been done in chronically ventilated patients for more than 30 years. The procedure has multiple benefits. The patient's airway is easier to access, and the patient is more comfortable. 1 The most convincing argument is the stability of the airway once a tracheostomy has been placed and has matured. In the mid-1980s, Ciaglia et al 2 published their experience with PDT and clearly showed that this new method was safe. In August 1992, we began using PDT at East Texas Medical Center and Trinity Mother Frances hospitals in Tyler, Texas. The following is a report of the first 300 PDT procedures.
MATERIALS AND METHODS
From August 1992 to October 1998, we collected data on 300 consecutive critically ill patients. All intubated trauma patients were assessed at approximately day 7. The patient was a candidate for PDT if the attending trauma surgeon believed the patient needed at least 7 more days of mechanical ventilation. Consultations for tracheostomy from medical and surgical services were included in this study if the procedure was done by the trauma service. All patients who were considered candidates for open tracheostomy were included in the study group. Patients with a short fat neck, cervical fracture, and "uncleared" cervical spine were candidates for PDT. Patients receiving significantly high positive end-expiratory pressure (PEEP) ventilation (≥10) were excluded. We have noted significant desaturations in some patients who require high PEEP when the ventilator was disconnected from the patient. During a PDT, airway pressure is lost for a brief time. All PDTs were done in the intensive care unit (ICU) unless the patient was undergoing a simultaneous operation that required general anesthesia.
The data were analyzed using SigmaStat for Windows 2.03 (SPSS Inc, Chicago, Ill). The Fisher's Exact test was used to analyze 2 x 2 contingency tables that included low frequencies.
TECHNICAL ASPECTS OF THE PROCEDURE
The details of PDT have been described in multiple publications. 2, 3 The following are technical alterations that we have found useful.
After being placed on appropriate levels of mechanical ventilation and 100% oxygen delivered via the existing endotracheal tube, all patients were sedated with midazolam and paralyzed with vecuronium. Narcotics were routinely used. We modified the Ciaglia technique down to the trachea. Peak airway pressures were limited to 40 cm H 2 O by reducing the patient's tidal volumes. For the majority of cases, the procedure was done by a surgeon and a second physician/bronchoscopist with a respiratory therapist, and a "circulating" critical care nurse was available for assistance. The respiratory therapist dedicated to the ICU was trained to direct the videoscope. When this procedure was done without an assisting surgeon, 2 ICU nurses, 2 respiratory therapists, and a trauma surgeon assisted. Every patient had continuous monitoring with pulse oximetry and electrocardiographic monitoring.
RESULTS
A total of 300 consecutive patients were entered into the study. There were 161 trauma patients, 114 medical patients, and 25 cardiac surgery patients (Table 1 ). There were 12 complications (Table 2 ) and 1 death.
The death occurred in a 75-year-old woman who was admitted to the ICU because of respiratory failure due to chronic obstructive pulmonary disease. The patient had a long history of coronary artery disease. During the procedure, she was noted to have complete tracheal collapse during inspiration. The PDT was done without immediate problems. Approximately 15 minutes later, the patient was cyanotic, with decreasing oxygen saturations. The bronchoscope was placed into the tracheostomy tube, which was found to be within the tracheal lumen. The ventilator was functioning properly. The patient was orally intubated, and the tracheostomy tube was removed. The patient's condition continued to deteriorate. Bilateral chest tubes were placed. The patient was now in asystole. Despite efforts in accordance with protocols of the Advanced Cardiac Life Support, the patient died. Autopsy revealed bilateral ruptured apical blebs and tracheal malacia.
We have chosen to compare our results with those of several recent reports, [5] [6] [7] [8] and the 1994 follow-up report by Ciaglia and Graniero. 4 For this analysis to be valid, several assumptions have to be made. The patient populations must be equivalent. Injury severity scores, APACHE scores, and other physiologic parameters should be similar for the comparisons to have any meaning. Papers from English-speaking countries were used exclusively. All of the studies included in this analysis used the commercially available PDT kit (Cook Critical Care, Bloomington, Ind). Table 3 is a detailed list of complications in our study and the 5 other studies. Any death occurring in the perioperative period was attributed to the PDT. Unusual erythema surrounding the tracheostomy site was considered cellulitis. In Table 4 , we have combined the results from the 5 articles and compared those with our results. There was no significant difference between our outcome and the combined results in any of the listed categories of the comparison group using Fisher's Exact test. The number of tracheal tears that we found was significantly greater than in the combined group (P = .014).
DISCUSSION
Although we found more than 50 articles on PDT, most of the papers discuss the ability to perform the procedure. From this current study, several conclusions can be made. The safety of this technique is clearly established. Mortality from PDT is rare, but it does occur. To decrease mortality, we suggest using bronchoscopic guidance during the procedure. The most challenging portion of the procedure is placing the introducer needle into the proper location in the anterior trachea. Several authors 4, 9, 10 have suggested the importance of aspirating during placement of the inducer needle into the trachea. We agree with this recommendation. Although aspirating air is comforting, it does not rule out placement of the introducer needle into the esophagus. Bronchoscopic guidance has not been previously proven to be effective. There were no paratracheal placements in the 2 studies that used bronchoscopic guidance, whereas a total of 10 paratracheal placements occurred in the other studies. There was also a trend toward significance (P = .130) when comparing our data with data from the other 5 studies. This suggests a possible benefit to using the bronchoscope to prevent paratracheal placement. Using bronchoscopic guidance can help prevent the surgeon from puncturing through the trachea into the esophagus. In young patients, the tracheal rings are very compliant. The trachea can easily collapse under the pressure of the introducer needle. Bronchoscopic guidance can help the surgeon see the collapse of the trachea and alter the angle at which the needle enters the trachea or take other corrective action. Judgment in patient selection is critical to decreasing the risk of the procedure. Patients who require high mean or peak airway pressures may not be able to tolerate the loss of airway pressure that is associated with tracheostomy. One possible way to assess a patient for PDT is to remove the patient from the ventilator for 10 to 15 seconds. If the patient desaturates during this trial, he will not be able to tolerate the tracheostomy.
Sudden desaturation in a patient who just had a PDT should cause the surgeon to act quickly. The differential diagnosis would include tension pneumothorax and misplacement or dislodgement of the tracheostomy tube. These patients should be immediately orally intubated with bilateral chest decompressions (large bore needle placed in the second intercostal space along the midclavicular line).
Tracheal dislodgement has been the Achilles heel of all tracheostomies for decades. Dislodgement in PDT can lead to severe respiratory distress and possibly death. The newly dilated tract into the trachea usually closes within seconds if the tube is removed. Attempts at forcing a tube into this tract are usually not successful and are ill advised. If the PDT tube becomes dislodged, the patient should be orally intubated. The best way to prevent this complication is to take precautionary measures. Once the PDT is placed, we suggest suturing the tube in place and securing the tube by using umbilical tape though the eyelets of the tracheostomy tube and tying the tape around the neck. Sedation for agitated patients is paramount. Patients with fresh PDT (within the first 7 to 10 days) should probably be sedated to a Ramsay sedation score of 2 or 3.
11 Both ICU nurses and respiratory therapists must be acutely aware of this potentially fatal complication. Ventilator tubing should be secured in such a way as to prevent pulling on the newly placed tracheostomy tube and thus prevent accidental dislodgement.
Cellulitis was not strictly defined in any of the studies included in this review. Therefore, the exact incidence is not truly known. It appears that infections around the PDT are rare. A short course of antibiotics and local wound care should be all that is needed. If the erythema persists, one should rule out a neck abscess.
Tracheal tears were reported in only two studies. 6 In the studies that did not use bronchoscopically guided techniques, no tracheal tears were noted. The incidence of posterior wall injury appears to be low. No patient had serious sequellae due to this injury. Therefore, the significance of making the diagnosis is unclear.
Bleeding is the most frequent complication in the combined data. As with all patients having surgery, it is paramount that the patient does not have a coagulopathy. Only 2 of the total 1,236 patients required transfusion; there- fore, most bleeding is minor. One study 6 included a relatively large number of patients requiring dialysis for renal failure. Because several of these patients did have bleeding after the procedure, we recommend that the platelet count, prothrombin time, and partial thromboplastin time be measured before PDT in all patients who have renal failure.
All patients having PDT should have chest radiography afterward. The overall incidence of pneumothorax is 0.56%. If further studies delineate which patients are at greater risk for pneumothorax, chest films could be obtained more selectively. Care should be taken to avoid high airway pressures and posterior tracheal trauma during the procedure. As our study shows, PDT can be done safely in a community hospital and with the same low morbidity and mortality rates reported in large university hospitals.
